Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease
Mediators of Inflammation · 2023
DOI: 10.1155/2023/9715114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Nazirah Samah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Coronary Artery Disease, Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Malaysia.
Abstract (Originalsprache)
Coronary artery disease (CAD) is a caused by atherosclerotic plaque buildup in the coronary arteries that supply blood and oxygen to the heart. Matrix metalloproteinase (MMP) is a family of zinc-dependent endopeptidase that is involved in various stages of atherosclerosis as demonstrated in in vitro and in vivo studies. MMP-2 is associated with both stable and unstable atherosclerotic plaque formation. The current review aimed to identify the role of MMP-2 in atherosclerosis development among CAD patients. Literature search was conducted through four online databases and only studies that were published from 2018 until February 2023 were included. The risk of bias was assessed by using the Newcastle–Ottawa Scale. A total of 10,622 articles were initially identified, and only eight studies that fulfilled the selection criteria were included in this review. The results showed that MMP-2 levels and activity were higher in patients with unstable CAD than those with stable CAD and healthy subjects. There was a significant association between MMP-2 levels and cardiovascular disease with MMP-14 levels, which is a pro-MMP-2 activator. In addition, two single nucleotide polymorphisms of the MMP-2 gene (rs243865 and rs243866) were significantly associated with the development of atherosclerosis. In conclusion, MMP-2 plays a crucial role in the development of atherosclerosis among patients with CAD and could be a potential target for CAD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia.
- Centre for Tissue Engineering & Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Cheras, Kuala Lumpur, Malaysia.
ORCID-Profile: Nazirah Samah, Azizah Ugusman, Adila A Hamid, Nadiah Sulaiman, Amilia Aminuddin
Förderung
- Ministry of Higher Education, Malaysia
Zitieren
APA
Samah, N., Ugusman, A., Hamid, A. A., Sulaiman, N., & Aminuddin, A. (2023). Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease. Mediators of Inflammation. https://doi.org/10.1155/2023/9715114
Vancouver
Samah N, Ugusman A, Hamid AA, Sulaiman N, Aminuddin A. Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease. Mediators of Inflammation. 2023. doi:10.1155/2023/9715114
BibTeX
@article{Samah2023,
author = {Samah, Nazirah and Ugusman, Azizah and Hamid, Adila A and Sulaiman, Nadiah and Aminuddin, Amilia},
title = {Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease},
journal = {Mediators of Inflammation},
year = {2023},
doi = {10.1155/2023/9715114}
}
EUVIMED